Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationHematopoietic Stem CellsGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousStem CellsBone MarrowBone Marrow CellsTransplantation ChimeraHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTissue DonorsLiver TransplantationGraft SurvivalBusulfanWhole-Body IrradiationTreatment OutcomeLeukemiaHistocompatibility TestingRecurrenceGraft vs Leukemia EffectRemission InductionKidney TransplantationMyeloablative AgonistsImmunosuppressive AgentsHistocompatibilityAnemia, AplasticGraft vs Tumor EffectLeukemia, Myeloid, AcuteHematopoiesisCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCord Blood Stem Cell TransplantationRetrospective StudiesVidarabineLymphocyte TransfusionHematopoietic Stem Cell MobilizationCyclophosphamideTime FactorsAntigens, CD34Myelodysplastic SyndromesLymphocyte DepletionMultiple MyelomaCell DifferentiationPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisCytomegalovirus InfectionsHepatic Veno-Occlusive DiseaseTransplantation, IsogeneicTransplantation ImmunologyMice, Inbred C57BLSurvival RateDisease-Free SurvivalMesenchymal Stem Cell TransplantationHeart TransplantationChimerismGraft RejectionT-LymphocytesSiblingsAntilymphocyte SerumCell TransplantationEmbryonic Stem CellsSalvage TherapyAcute DiseaseMinor Histocompatibility AntigensMelphalanHLA AntigensImmunosuppressionBone and BonesHematologic DiseasesAdult Stem CellsLung TransplantationFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsNeoplasm, ResidualLeukemia, MyeloidCell LineageFollow-Up StudiesColony-Forming Units AssayBone Marrow PurgingStem Cell NicheGranulocyte Colony-Stimulating FactorCells, CulturedOrgan TransplantationLymphoma, Non-HodgkinVirus ActivationRadiation ChimeraPrognosisCytarabineCyclosporineCytomegalovirusLeukocyte TransfusionPrimary MyelofibrosisCell SeparationNuclear FamilyImmunocompromised HostMesenchymal Stromal Cells